Cary Street Partners Investment Advisory’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,000
Closed -$21K 1814
2023
Q1
$21K Hold
5,000
﹤0.01% 959
2022
Q4
$30.1K Buy
+5,000
New +$30.1K ﹤0.01% 864